ACCENture CEO has been diagnosed with breast cancer, to undergo surgery next week

Jolly Switch, CEO of Acceneture, was diagnosed with breast cancer in the early stage, and treatment is likely to last from 12 to 16 weeks, according to the Moneycontrol report. However, the CEO will continue to care for the daily operations for information technology and consulting services during treatment.

“I was diagnosed with breast cancer recently. The good news is that the diagnosis of my doctor is excellent; cancer has been arrested early, and my condition is recovered.”

Her message added that the surveying operations have confirmed that there is no evidence of cancer elsewhere in the body. After surgery next week, additional treatment for more radiation.

Accenture is one of the largest information technology services heads with about 3 Luxa employees in India.

“As mentioned in the memo that Jolie sent to our people, her diagnosis was excellent, cancer was arrested early, and her condition is healable. It will work significantly as it is normal, and she continues to lead the company’s daily operation, Moneycontrol mentioned a spokesman for Acceneture.

However, it will reduce travel during this period. Accenture Board of Directors has been briefed and fully supports developments.

“We have an incredible global management committee, with the support of our amazing teams all over the world. I am sure that we will continue to do what we do better- the value of 360 degrees for our customers, individuals, shareholders, partners and societies,” read Sweet mail.

Sweet CEO of Accenture was appointed in September 2019. She previously worked as ACCENture CEO in North America, the company’s largest geographical market.

She also works in the Board of Trustees of the World Economic Forum.